Literature DB >> 21550309

Early diagnosis and management of postpartum hemolytic uremic syndrome with plasma exchange.

Manisha Shrivastava1, Gopesh Modi, Rakesh Kumar Singh, Seema Navaid.   

Abstract

The likelihood of survival in cases of postpartum hemolytic uraemic syndrome (HUS) is as high as 80-90% with early diagnosis and aggressive treatment using plasma exchange (PE). The patients, referred to our center, diagnosed as postpartum HUS presented with thrombocytopenia, microangiopathic hemolytic anaemia with or without fever and severe renal failure, were managed aggressively with PE in conjunction with hemodialysis. All patients showed clinical improvement, along with laboratory indicators like normal renal function tests, increased platelet counts and decreased lactic dehydrogenase levels. Awareness amongst treating physicians, early diagnosis and treatment with PE could be the key factors in reducing maternal mortality due to postpartum HUS in developing countries.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21550309     DOI: 10.1016/j.transci.2011.04.004

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  3 in total

Review 1.  Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.

Authors:  Arif Asif; Ali Nayer; Christian S Haas
Journal:  J Nephrol       Date:  2016-11-15       Impact factor: 3.902

2.  Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review.

Authors:  Megha Gupta; Shravya Govindappagari; Richard M Burwick
Journal:  Obstet Gynecol       Date:  2020-01       Impact factor: 7.623

3.  Role of plasma exchange in postpartum microangiopathies: An experience from a tertiary care center.

Authors:  Rekha Hans; Satya Prakash; Divjot Singh Lamba; Ratti Ram Sharma; Pankaj Malhotra; Vanita Suri; Neelam Marwaha
Journal:  Asian J Transfus Sci       Date:  2019-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.